Mundipharma International Overview
- Year Founded
-
1952
- Status
-
Private
- Employees
-
2,257
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
2
- Investments
-
6
Mundipharma International General Information
Description
Manufacturer of pharmaceutical products intended to identify and accelerate the development of meaningful medicines. The company offers pain medicines and three other core therapeutic areas of respiratory, oncology and biosimilar, enabling its patients to avail the treatment of challenging health conditions and lead a healthy life.
Contact Information
Website
www.mundipharma.comCorporate Office
- Cambridge Science Park
- Milton Road
- Cambridge CB4 0AB
- England, United Kingdom
Corporate Office
- Cambridge Science Park
- Milton Road
- Cambridge CB4 0AB
- England, United Kingdom
Mundipharma International Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Mundipharma International Comparisons
Industry
Financing
Details
Mundipharma International Competitors (60)
One of Mundipharma International’s 60 competitors is Esperion Therapeutics, a Formerly VC-backed company based in Ann Arbor, MI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Esperion Therapeutics | Formerly VC-backed | Ann Arbor, MI | ||||
| Spear Pharmaceuticals | Formerly PE-Backed | Randolph, NJ | ||||
| Pfizer Manufacturing Austria | Corporation | Orth An Der Donau, Austria | ||||
| Alvogen Group | Private Equity-Backed | Morristown, NJ | ||||
| Pfizer Pakistan | Corporation | Karachi, Pakistan |
Mundipharma International Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Mundipharma International Patents
Mundipharma International Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201909594-D0 | Etoposide toniribate formulation | Inactive | 03-Jul-2019 | ||
| GB-201909584-D0 | Etoposide toniribate formulation | Inactive | 03-Jul-2019 | ||
| GB-201908436-D0 | Compounds for treating multiple myeloma | Inactive | 12-Jun-2019 | ||
| GB-201908434-D0 | Compounds for treating lymphoma or a t-cell malignant disease | Inactive | 12-Jun-2019 | ||
| GB-201903005-D0 | Compounds for treating multiple myeloma | Inactive | 06-Mar-2019 |
Mundipharma International Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Mundipharma International Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Mundipharma International Investments & Acquisitions (6)
Mundipharma International’s most recent deal was a Buyout/LBO with Cidara Therapeutics (Rezafungin Aseests and Rights) for . The deal was made on 24-Apr-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Cidara Therapeutics (Rezafungin Aseests and Rights) | 24-Apr-2024 | Buyout/LBO | Buildings and Property | ||
| Cinfa Biotech | 10-Oct-2018 | Merger/Acquisition | Pharmaceuticals | ||
| CellAct Pharma | 14-Aug-2017 | Later Stage VC | Drug Discovery | ||
| CellAct (Commercialization and manufacturing rights to CAP7.1) | 07-Aug-2017 | Corporate Asset Purchase | Buildings and Property | ||
| Phoenux (patent rights for heroin substitution preparations) | 20-Jan-2014 | Corporate Asset Purchase | Buildings and Property |
Mundipharma International Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Mundipharma China Pharmaceutical | Beijing, China | 1993 |
Mundipharma International FAQs
-
When was Mundipharma International founded?
Mundipharma International was founded in 1952.
-
Where is Mundipharma International headquartered?
Mundipharma International is headquartered in Cambridge, United Kingdom.
-
What is the size of Mundipharma International?
Mundipharma International has 2,257 total employees.
-
What industry is Mundipharma International in?
Mundipharma International’s primary industry is Pharmaceuticals.
-
Is Mundipharma International a private or public company?
Mundipharma International is a Private company.
-
What is Mundipharma International’s current revenue?
The current revenue for Mundipharma International is .
-
Who are Mundipharma International’s investors?
NovaQuest Capital Management has invested in Mundipharma International.
-
Who are Mundipharma International’s competitors?
Esperion Therapeutics, Spear Pharmaceuticals, Pfizer Manufacturing Austria, Alvogen Group, and Pfizer Pakistan are some of the 60 competitors of Mundipharma International.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
